Genscript Biotech Co. (OTCMKTS:GNNSF) Sees Significant Decrease in Short Interest

Genscript Biotech Co. (OTCMKTS:GNNSFGet Free Report) saw a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 4,748,000 shares, a decrease of 13.9% from the August 15th total of 5,515,500 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 47,480.0 days.

Genscript Biotech Price Performance

OTCMKTS:GNNSF remained flat at C$2.42 during mid-day trading on Tuesday. The stock has a fifty day simple moving average of C$2.19 and a two-hundred day simple moving average of C$2.36. Genscript Biotech has a 52-week low of C$1.89 and a 52-week high of C$3.53.

Genscript Biotech Company Profile

(Get Free Report)

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products, Biologics Development Services, Industrial Synthetic Biology Products, and Cell Therapy.

Featured Stories

Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with's FREE daily email newsletter.